Live Breaking News & Updates on Lam Kong

Stay updated with breaking news from Lam kong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

HONG KONG, Mar 31, 2023 - (ACN Newswire) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1].From left to right: CEO of Junshi Biosciences,. ....

United States , Chong Tan , Republic Of , United Kingdom , Junshi Biosciences , Xiong Jun , China Medical System Holdings Limited , Rxilient Biotech , Legend Capital , Managing Director , Executive Director , Chief Executive , Lam Kong , Lee Ker , Southeast Asia , Southeast Asian ,


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Republic Of , Chong Tan , United Kingdom , Junshi Biosciences , Xiong Jun , China Medical System Holdings Limited , Joint Venture , Rxilient Biotech , Legend Capital , Managing Director , Executive Director , Chief Executive , Lam Kong , Lee Ker , Southeast Asia , Southeast Asian , Acn Newswire ,

Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia

02.12.2022 - Incyte (NASDAQ:INCY) and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS (HKEX: 00867), today announced that the companies have entered into a Collaboration and License Agreement for the development and . Seite 1 ....

United States , Hong Kong , Chief Executive Officer , Greater China , Southeast Asia , Lam Kong , Chief Executive ,